EBIT: Income before interest and taxes.
KALA BIO, Inc. (KALA) had EBIT of $-39.66M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-42.20M |
|
-- |
|
-- |
|
$39.66M |
|
$-39.66M |
|
$-2.54M |
|
$-42.20M |
|
$-42.20M |
|
$-42.20M |
|
$-42.20M |
|
$-42.20M |
|
$-42.20M |
|
|
EBIT |
$-39.66M |
$-38.11M |
|
2.43M |
|
2.43M |
|
$-17.35 |
|
$-17.35 |
|
| Balance Sheet Financials | |
$52.87M |
|
$0.75M |
|
$3.08M |
|
$55.95M |
|
$8.35M |
|
$38.30M |
|
$40.10M |
|
$48.45M |
|
$7.50M |
|
$7.50M |
|
$7.50M |
|
2.76M |
|
| Cash Flow Statement Financials | |
$-27.93M |
|
$-0.43M |
|
$8.51M |
|
$70.75M |
|
$50.90M |
|
$-19.85M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.33 |
|
-- |
|
-- |
|
0.84 |
|
5.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-562.36% |
|
-562.35% |
|
-75.42% |
|
-92.13% |
|
$2.72 |
|
$-11.71 |
|
$-11.48 |
|